Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Olaparib, Durvalumab for I-SPY 2 Trial Announces

americanpharmaceuticalreviewSeptember 10, 2018

Tag: Olaparib , I-SPY 2 , AstraZeneca

PharmaSources Customer Service